June 27, 2024
by Roman Kasianov
News
Researchers at the Arc Institute in California have identified a novel DNA-editing mechanism in bacteria, dubbed the “bridge editing” system, …
June 27, 2024
by Andrii Buvailo
Biopharma insight
(Last Update: May, 2024, by adding Labviva and more) A life sciences marketplace is an online platform that operates with a "many-to-many" business …
June 26, 2024
by Roman Kasianov
News
Formation Bio, an AI-native pharmaceutical company, has raised $372 million in Series D financing, led by a16z and Sanofi. Additional …
June 26, 2024
by Roman Kasianov
News
Evaxion Biotech A/S, a clinical-stage TechBio company known for its AI-Immunology™ powered vaccines, has received favorable feedback regarding its recent …
June 25, 2024
by Roman Kasianov
News
EvolutionaryScale has introduced its latest generative AI model, ESM3, which leverages NVIDIA H100 GPUs to enhance protein research and discovery. …
June 24, 2024
by Roman Kasianov
News
Cromatic, a startup focused on life sciences research outsourcing, has introduced an AI-powered tool named Sourcerer. This tool is designed …
June 19, 2024
by Roman Kasianov
Biopharma insight
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As …
June 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
In the rapidly evolving life sciences and healthcare landscape, the secure and privacy-preserving exchange and linkage of health data is …
June 18, 2024
by Andrii Buvailo
Biopharma insight
Among many important helathcare tech topics discussed at the inagural HLTH Europe 2024 conference taking place on June 17-20 in …
June 18, 2024
by Roman Kasianov
News
Basecamp Research, in collaboration with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona, has introduced ZymCTRL, an …
June 18, 2024
by Natalia Honchar
Biopharma insight
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences …
June 17, 2024
by Roman Kasianov
News
Enveda Biosciences has successfully raised $55 million in a Series B2 financing round, bringing its total capital raised to $230 …